Tech Company Financing Transactions

EdiGene Funding Round

On 4/11/2019, EdiGene announced $15 million in Series B financing from CareNet, Fast Track Initiative and Mizuho Capital of Japan.

Transaction Overview

Company Name
Announced On
4/11/2019
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series B
Proceeds Purpose
EdiGENE plans to use the proceeds of the financing to advance the groundbreaking science forward, extend its leadership position in gene modulation technology, and progress pipeline programs towards the clinic where they will impact patients suffering from serious genetic diseases.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
245 1st St. Riverview II 18th Floor
Cambridge, MA 02142
USA
Phone
Undisclosed
Email Address
Overview
EdiGene is a world leading genome editing company founded in 2015. The mission of EdiGene is to translate the cutting-edge genome editing technologies into novel therapeutics for genetic diseases and cancer, and into creative solutions to advance drug discovery.
Profile
EdiGene LinkedIn Company Profile
Social Media
EdiGene Company Twitter Account
Company News
EdiGene News
Facebook
EdiGene on Facebook
YouTube
EdiGene on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Dong Wei
  Dong Wei LinkedIn Profile  Dong Wei Twitter Account  Dong Wei News  Dong Wei on Facebook
Chief Operating Officer
David Si
  David Si LinkedIn Profile  David Si Twitter Account  David Si News  David Si on Facebook
Chief Technical Officer
Pengfei Yuan
  Pengfei Yuan LinkedIn Profile  Pengfei Yuan Twitter Account  Pengfei Yuan News  Pengfei Yuan on Facebook
Founder
Wensheng Wei
  Wensheng Wei LinkedIn Profile  Wensheng Wei Twitter Account  Wensheng Wei News  Wensheng Wei on Facebook
VP - R & D
Riguo Fang
  Riguo Fang LinkedIn Profile  Riguo Fang Twitter Account  Riguo Fang News  Riguo Fang on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/11/2019: Extend venture capital transaction
Next: 4/11/2019: Scout Bio venture capital transaction

 

Share this article

 


About Database of VC Transactions

Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary